CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.
Check out our portfolio of awards below. Click here to see a list of People We’ve Funded.
All CIRM Grants
Search Filters »
Institution |
Researcher name |
Grant Type |
Grant Title |
Award Value |
University of California, Los Angeles |
Dr. Brigitte N Gomperts |
Conference – Lung Regenerative Medicine Workshop |
Stem Cells for Lung Diseases – Overcoming Barriers to Find New Therapies |
$44,548 |
IQVIA, Inc. |
Dr. Amritha Jaishankar |
Translating Center |
A Translating Center designed to expedite the development and delivery of high quality stem cell therapies to patients |
$15,000,000 |
IQVIA, Inc. |
Peter Robinson |
Accelerating Center |
An Accelerating Center designed to expedite the development and delivery of high quality stem cell therapies to patients |
$11,772,453 |
University of California, San Diego |
Catriona Jamieson |
Conference – The 2016 Alpha Stem Cell Clinic Annual Symposium |
UCSD Division of Regenerative Medicine and CIRM Alpha Clinics Network Symposium |
$37,778 |
Mosaic Event Management, Inc. |
Ron Johnson |
Conference – Manage The 2016 Bridges And SPARK Annual Meetings |
2016 CIRM Bridges & SPARK Meetings |
$205,388 |
University of California, Irvine |
Dr. Aileen J Anderson |
Quest – Discovery Stage Research Projects |
Therapeutic targeting of Glioblastoma Stem Cell survival and self-renewal signaling |
$2,250,144 |
Children’s Hospital of Los Angeles |
Dr Biraj Mahato |
Quest – Discovery Stage Research Projects |
Chemically engineered photoreceptors for vision restoration in retinal degeneration associated blindness. |
$1,711,000 |
University of California, San Francisco |
Claire Clelland |
Quest – Discovery Stage Research Projects |
Developing a universal CRISPR gene therapy approach to treat C9orf72 ALS |
$2,740,592 |
University of California, Los Angeles |
Dr. Koki Morizono |
Quest – Discovery Stage Research Projects |
B cell receptor-mediated lentiviral expression of anti-HIV antibody |
$2,751,504 |
University of California, San Francisco |
Faranak Fattahi |
Quest – Discovery Stage Research Projects |
Drug discovery for Charcot Marie Tooth Disease using hPSC-derived Schwann cells |
$2,471,664 |
City of Hope, Beckman Research Institute |
Dr. Christine E. Brown |
Quest – Discovery Stage Research Projects |
Development of a Trifunctional Self-Renewing Memory CAR T Cell Therapy to Overcome the Heterogeneity and Suppressive Microenvironment of Glioblastoma |
$2,700,810 |
University of California, San Diego |
Dr. Neil Carson Chi |
Quest – Discovery Stage Research Projects |
Modulating cardiac myosin heavy chain isoform expression for treating cardiomyopathies |
$2,772,000 |
University of California, San Francisco |
Dr. Qizhi Tang PhD |
Quest – Discovery Stage Research Projects |
Genome editing of human Tregs to enable combinational tolerogenic therapy with T cell-targeted biologics for T1D |
$2,485,549 |
Palo Alto Veterans Institute for Research |
Dr Jian Luo |
Quest – Discovery Stage Research Projects |
Human induced pluripotent stem cells-derived glial enriched progenitors for the treatment of mild traumatic brain injury |
$2,255,189 |
Palo Alto Veterans Institute for Research |
Irene Lorenzo Llorente |
Quest – Discovery Stage Research Projects |
Inhibitory interneurons derived from human induced pluripotent stem cells to treat stroke |
$2,140,122 |
Savanna Biotherapeutics, Inc. |
Dr. Sunil Gandhi Ph.D |
Quest – Discovery Stage Research Projects |
Gene-corrected human microglia for the treatment of adult onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) |
$1,417,948 |
University of California, San Francisco |
Faranak Fattahi |
Quest – Discovery Stage Research Projects |
Drug discovery for gastrointestinal motility disorders using hPSC-derived enteric ganglioids |
$1,954,367 |
University of Southern California |
Dr. Justin K Ichida |
Quest – Discovery Stage Research Projects |
Development of a VAV2 antisense oligonucleotide (ASO) treatment for ALS |
$2,072,560 |
Cedars-Sinai Medical Center |
Dr. Ritchie Ho |
Quest – Discovery Stage Research Projects |
C9orf72 repeat expansion-tuned allelic suppression by CRISPRi as an ALS therapy |
$2,274,768 |
University of California, Davis |
Ricardo Anibal Maselli MD |
Quest – Discovery Stage Research Projects |
Treatment of Myasthenic Syndrome due to Choline Acetyltransferase Deficiency Using AAV9-mediated Gene Therapy |
$1,500,000 |
Adverum Biotechnologies |
Cameron Keast Baker |
Quest – Discovery Stage Research Projects |
Development of an Optogenetic Vision Restoration Gene Therapy Using an Engineered Form of Melanopsin |
$1,150,820 |
Stanford University |
Dr. Robert Negrin MD |
Quest – Discovery Stage Research Projects |
Orthogonal IL2 Receptor Transduced Regulatory T Cells for Clinical Application |
$1,920,652 |
University of California, San Francisco |
Michael Wilson |
Quest – Discovery Stage Research Projects |
A First-in-Class Treatment for Progressive Multifocal Leukoencephalopathy Via Multimodal Immune System Engineering |
$2,182,396 |
Stanford University |
Dr. Michael F Clarke |
Quest – Discovery Stage Research Projects |
Developing a breast cancer stem cell drug |
$2,053,727 |
Cedars-Sinai Medical Center |
Dr. Ke Liao |
Quest – Discovery Stage Research Projects |
RNA-based therapeutics to augment regulatory T cells: a novel approach to treat myocarditis |
$2,264,509 |
University of California, Irvine |
Jianhua Yu |
Quest – Discovery Stage Research Projects |
Reprogramming Somatic Cells into iPSCs Engineered with an Anti-PSCA CAR to Develop Allogeneic Off-the-Shelf Cell Therapy to Treat Pancreatic Cancer |
$1,509,000 |
University of Southern California |
Dr Linda Sher |
Quest – Discovery Stage Research Projects |
Assessing the Functional, Immunologic and Microbiologic Characteristics of Human Livers Created in Chimeric Pigs |
$2,736,590 |
City of Hope, Beckman Research Institute |
Dr Jianhua Yu |
Quest – Discovery Stage Research Projects |
Reprogramming Somatic Cells into iPSCs Engineered with an Anti-PSCA CAR to Develop Allogeneic Off-the-Shelf Cell Therapy to Treat Pancreatic Cancer |
$525,468 |
Vertuis Bio, Inc. |
Lukas Bachmann |
Quest – Discovery Stage Research Projects |
Expanded Capacity AAV Retinal Gene Therapy Enabled by Efficient RNA-Joining Technology |
$0 |
Gladstone Institutes, J. David |
Lyandysha (Lana) Viktorovna Zholudeva |
Quest – Discovery Stage Research Projects |
Excitatory spinal interneurons from human pluripotent stem cells to treat spinal cord injury |
$2,942,198 |
University of California, Los Angeles |
Prof. Song Li |
Quest – Discovery Stage Research Projects |
Vax-CT to promote formation of cancer-specific T memory stem cell for personalized cancer immunotherapy |
$2,267,714 |
University of California, Los Angeles |
Dr. Richard Joseph Pietras |
Quest – Discovery Stage Research Projects |
Reversal of dysregulated myelopoiesis in breast cancers and cancer stem cells to boost antitumor immunotherapy |
$2,327,680 |
Greenstone Biosciences, Inc. |
Paul D Pang |
Quest – Discovery Stage Research Projects |
Drug Discovery for Duchenne Muscular Dystrophy Using Patient-Derived Human iPSCs |
$675,000 |
University of California, Berkeley |
Mr. Fyodor Urnov |
Quest – Discovery Stage Research Projects |
A Treatment for Artemis-deficient Severe Combined Immunodeficiency using Non-Viral CRISPR-driven Safe Harbor Transgenesis in Hematopoietic Stem Cells |
$1,809,372 |
University of California, Davis |
Aijun Wang PhD |
Quest – Discovery Stage Research Projects |
In Utero Treatment of Duchenne Muscular Dystrophy with Non-viral Gene Editing |
$2,035,544 |
Rubedo Life Sciences Inc. |
Marco Quarta |
Quest – Discovery Stage Research Projects |
Pharmacological regenerative treatment of idiopathic pulmonary fibrosis targeting the senescent niche of lung progenitor cells. |
$1,450,876 |
University of California, Los Angeles |
Dr. Gerald Lipshutz |
Quest – Discovery Stage Research Projects |
Gene Therapy for SLC6A8 Creatine Transporter Disorder |
$2,296,920 |
University of California, Los Angeles |
Frank Pajonk |
Quest – Discovery Stage Research Projects |
Development of novel small molecules against cancer stem cells in solid cancers |
$2,340,000 |
Scripps Health |
Dr. Darryl D. D’Lima |
Quest – Discovery Stage Research Projects |
Pluripotent Stem Cells for Tendon Tissue Engineering |
$2,734,163 |
Cedars-Sinai Medical Center |
Dmitriy Sheyn |
Quest – Discovery Stage Research Projects |
Microgel encapsulated iPSC-derived notochordal cells to treat intervertebral disc degeneration and low back pain |
$2,020,166 |
Lundquist Institute for Biomedical Innovation at Harbor – UCLA Medical Center |
Dr. Michelina Iacovino PhD |
Quest – Discovery Stage Research Projects |
A Novel Therapy for Sanfilippo B |
$2,297,884 |
University of California, Berkeley |
Kevin E. Healy |
Quest – Discovery Stage Research Projects |
Novel Lipid Nanoparticles for Enhancing eNOS Synthesis for Cardioprotection Post Myocardial Infarction |
$2,060,248 |
BrainXell Therapeutics |
Matthew Goodus |
Quest – Discovery Stage Research Projects |
Autologous stem cell-derived interneuron cell therapy for spinal cord injury (SCI) |
$2,025,000 |
University of California, San Diego |
Professor Alysson R Muotri |
Quest – Discovery Stage Research Projects |
A treatment for Rett syndrome using glial-restricted neural progenitor cells |
$1,402,240 |
Gladstone Institutes, J. David |
Dr. Deepak Srivastava |
Quest – Discovery Stage Research Projects |
Modified RNA-Based Gene Therapy for Cardiac Regeneration Through Cardiomyocyte Proliferation |
$1,565,784 |
The Scintillon Institute |
Brian Lawson |
Quest – Discovery Stage Research Projects |
An hematopoietic stem-cell-based approach to treat HIV employing CAR T cells and anti-HIV broadly neutralizing antibodies. |
$1,143,600 |
University of California, Irvine |
Dr. Michael Demetriou |
Quest – Discovery Stage Research Projects |
CAR T cells targeting abnormal N-glycans for the treatment of refractory/metastatic solid cancers |
$1,414,800 |
University of California, Los Angeles |
Dr. Lili Yang |
Quest – Discovery Stage Research Projects |
Combating Ovarian Cancer Using Stem Cell-Engineered Off-The-Shelf CAR-iNKT Cells |
$1,402,662 |
Minutia, Inc. |
Katy Digovich |
Quest – Discovery Stage Research Projects |
Bioengineering human stem cell-derived beta cell organoids to monitor cell health in real time and improve therapeutic outcomes in patients |
$1,198,550 |
Nanotools Bioscience |
Dr. Alex Savtchenko PhD |
Quest – Discovery Stage Research Projects |
Enabling non-genetic activity-driven maturation of iPSC-derived neurons |
$675,000 |